|
|
 |
|
News/Event Item
The Pfizer Foundation 2007 - 2009 HIV/AIDS Initiative
Pfizer Inc and the Pfizer Foundation are announcing a three-year HIV/AIDS initiative (2007 - 2009) to complement existing HIV prevention efforts and to address the need for the HIV/AIDS community to engage in holistic approaches linking prevention, care and treatment programs.
The Pfizer Foundation is committed to funding innovative and comprehensive programs along the continuum of prevention and care services for high-risk HIV-negative and/or at-risk HIV-positive persons and their sex and/or needle-sharing partners. Grants will be awarded under the following four categories: (1) Prevent infections among high-risk HIV-negative persons; (2) Prevent transmission from HIV-positive persons to their at-risk sex and/or needle sharing partners; (3) Link persons living with HIV into high quality care and treatment services; and (4) Promote adherence and delay disease progression among persons living with HIV.
In particular, the Pfizer Foundation is most interested in funding programs (including harm reduction programs) that are founded on evidence-based interventions, including "homegrown" and hybrid models, and that focus on breaking down the barriers or the divisions between:
(1) HIV prevention and other risk reduction programs: These programs should consider other health-related issues that increase risk for HIV infection, including STDs, hepatitis, drug use, mental health, homelessness, etc.; and (2) HIV/AIDS prevention and care: These programs should incorporate or link HIV prevention services (risk assessment, risk reduction education and counseling) for HIV-positive persons and their sex and/or needle-sharing partners into primary care settings, sexually transmitted disease clinics, drug treatment facilities or mental health settings.
For More Information, visit:
http://hivaidsphilanthropy.pfizer.com/
category: News from Other Sources : Awards & Grants
contributed by Olga Zhuykova on 13 November 2006
Global :
recall this item.
|
|
Share
